Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference36 articles.
1. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012;KW Jung;Cancer Res Treat,2015
2. Cancer statistics, 2015;RL Siegel;CA Cancer J Clin,2015
3. Economic Burden of Cancer in Korea during 2000–2010;KS Lee;Cancer Res Treat,2015
4. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib;GJ Riely;Clin Cancer Res,2006
5. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics;DR Parkinson;Clin Cancer Res,2012
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review;Critical Reviews in Oncology/Hematology;2024-10
2. Next-generation sequencing for pediatric CNS tumors: does it add value in a middle-income country setup?;Frontiers in Oncology;2024-02-19
3. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer;International Journal of Clinical Oncology;2023-08-13
4. Usefulness of on‐site cytology of liver tumor biopsy in specimen sampling for cancer genomic profiling test;Cancer Medicine;2023-01-11
5. Current Treatment Options for Cutaneous Adnexal Malignancies;Current Treatment Options in Oncology;2022-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3